Literature DB >> 16119629

Quality of life, depressive symptoms and anxiety in hyperthyroid patients.

A Suwalska1, K Lacka, D Lojko, J K Rybakowski.   

Abstract

PURPOSE: The aim of the study was to evaluate quality of life and to assess frequency and severity of depressive and anxiety symptoms in hyperthyroid patients.
MATERIAL AND METHODS: Forty-seven hyperthyroid patients (38 female, 9 male, mean age 51.4 +/- 13.0; 25-Graves disease, 22 - nodular goitre) and fifty-eight sex- and age-matched controls (40 female, 18 male, mean age 49.6 +/- 16.0) were studied. Quality of life was assessed by means of WHO QuoL Questionnaire. Psychometric evaluation included assessment of depressive symptoms (Hamilton Depression Rating Scale and Beck Depression Inventory) and anxiety level (State and Trait Anxiety Inventory--STAI).
RESULTS: Patients presented significantly decreased perception of quality of life and health state, and scored worse in physical domain and global score of WHO QuoL. Nineteen patients showed depressive symptoms, remaining 28 were euthymic. Level of anxiety did not differ significantly between the patients group and controls. Free thyroxine plasma level correlated with psychological domain of QuoL. Depression severity correlated with anxiety (STAI 2). Anxiety as a state marker influenced psychological and environmental domains and global score of quality of life questionnaire.
CONCLUSIONS: The influence of hyperthyroidism on the quality of life was observed. Depressive symptoms are frequent in hyperthyroidism, occurring in 40% hyperthyroid patients. We found also the association between the anxiety level and the quality of life.

Entities:  

Mesh:

Year:  2005        PMID: 16119629

Source DB:  PubMed          Journal:  Rocz Akad Med Bialymst


  5 in total

1.  Optimizing Levothyroxine Dose Adjustment After Thyroidectomy With a Decision Tree.

Authors:  Stephen S Chen; Nick A Zaborek; Amanda R Doubleday; Sarah C Schaefer; Kristin L Long; Susan C Pitt; Rebecca S Sippel; David F Schneider
Journal:  J Surg Res       Date:  2019-07-04       Impact factor: 2.192

2.  The association of thyroid stimulating hormone levels with cognitive function and depressed mood: the Rancho Bernardo study.

Authors:  D Kritz-Silverstein; S T Schultz; L A Palinska; D L Wingard; E Barrett-Connor
Journal:  J Nutr Health Aging       Date:  2009-04       Impact factor: 4.075

3.  Anxiety and depression are more prevalent in patients with graves' disease than in patients with nodular goitre.

Authors:  Kira Bang Bové; Torquil Watt; Asmus Vogel; Laszlo Hegedüs; Jakob Bue Bjoerner; Mogens Groenvold; Steen Joop Bonnema; Åse Krogh Rasmussen; Ulla Feldt-Rasmussen
Journal:  Eur Thyroid J       Date:  2014-09-02

4.  Influence of Thyroid Disorders upon the Incidence and the Severity of Psychosomatic Symptoms in Patients.

Authors:  Gordana Stanić; Marinković Snežana; Dragana Ristić Ignjatović
Journal:  Iran J Public Health       Date:  2022-08       Impact factor: 1.479

5.  Sex Differences in Dendritic Spine Formation in the Hippocampus and Animal Behaviors in a Mouse Model of Hyperthyroidism.

Authors:  Tetsushi Niiyama; Mahomi Kuroiwa; Yusaku Yoshioka; Yosuke Kitahara; Takahide Shuto; Tatsuyuki Kakuma; Keisuke Ohta; Kei-Ichiro Nakamura; Akinori Nishi; Mami Noda
Journal:  Front Cell Neurosci       Date:  2020-09-16       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.